Follow US:
Total funding of three grants exceeds $1.2 million
UC Riverside mouse study will identify mechanisms the gene PTPN2 uses to affect gut cells
UC Riverside-led study shows inhibiting two host cell proteases can accomplish the task
Research supported by five-year NIH grant may have relevance for COVID-19 patients
UC Riverside biomedical scientist Marcus Kaul explains
Drugs previously in development for SARS could be effective for COVID-19
NIH grant of $2.2 million could help researchers target two oncogenes, potentially leading to therapies for melanoma, lung cancer, and other tumors
UC Riverside-led study is the first to show how tofacitinib affects epithelial cells lining the gut
UC Riverside-led study tested the effects of microgravity on intestinal epithelial cells
UC Riverside mouse study finds early exposure to sounds can address hypersensitivity to noise associated with Fragile X Syndrome
The shape and architecture of collagen and elastin fibers can improve our understanding of lung diseases, including the one associated with vaping
UC Riverside-led research could aid regenerative stem cell therapies
Research is supported by a five-year grant to UC Riverside from the National Institutes of Health
UC Riverside-led mouse study focuses on cannabis-like molecules that augment feeding behavior
School of Medicine’s Nicholas DiPatrizio will lead a team tasked with assessing the impact of long-term cannabis exposure on metabolic health and disease
UC Riverside biomedical scientist’s decades-long work moves to clinical trials
Research could help reduce females’ susceptibility to several diseases, such as Fragile X and Rett syndromes
Multiple sclerosis is an autoimmune disease that affects more than 2.3 million people worldwide. This debilitating condition periodically shutters communication between the brain and other parts of the body, resulting in symptoms that range from numbness and tingling in the arms and legs to blindness and paralysis. While treatments are...
Scientists unlock new molecular secrets to unravel the mystery
Novel agents 135H11 and 135H12 move research closer to drug development
